Vertex Pharmaceuticals, Inc. (VRTX)
547.74
-0.31
(-0.06%)
USD |
NASDAQ |
Aug 24, 16:00
548.20
+0.46
(+0.08%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Liabilities (Quarterly) : 7.175B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.175B |
| March 31, 2026 | 7.122B |
| December 31, 2025 | 7.477B |
| September 30, 2025 | 7.544B |
| June 30, 2025 | 6.861B |
| March 31, 2025 | 6.384B |
| December 31, 2024 | 6.681B |
| September 30, 2024 | 6.609B |
| June 30, 2024 | 5.357B |
| March 31, 2024 | 5.371B |
| December 31, 2023 | 5.506B |
| September 30, 2023 | 5.213B |
| June 30, 2023 | 4.879B |
| March 31, 2023 | 4.542B |
| December 31, 2022 | 4.238B |
| September 30, 2022 | 3.677B |
| June 30, 2022 | 3.649B |
| March 31, 2022 | 3.349B |
| December 31, 2021 | 3.332B |
| September 30, 2021 | 3.088B |
| June 30, 2021 | 3.025B |
| March 31, 2021 | 3.135B |
| December 31, 2020 | 3.065B |
| September 30, 2020 | 3.168B |
| June 30, 2020 | 2.697B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.432B |
| December 31, 2019 | 2.233B |
| September 30, 2019 | 2.261B |
| June 30, 2019 | 1.964B |
| March 31, 2019 | 1.820B |
| December 31, 2018 | 1.811B |
| September 30, 2018 | 1.686B |
| June 30, 2018 | 1.621B |
| March 31, 2018 | 1.522B |
| December 31, 2017 | 1.504B |
| September 30, 2017 | 1.395B |
| June 30, 2017 | 1.418B |
| March 31, 2017 | 1.264B |
| December 31, 2016 | 1.559B |
| September 30, 2016 | 1.401B |
| June 30, 2016 | 1.380B |
| March 31, 2016 | 1.372B |
| December 31, 2015 | 1.405B |
| September 30, 2015 | 1.357B |
| June 30, 2015 | 1.326B |
| March 31, 2015 | 1.168B |
| December 31, 2014 | 1.238B |
| September 30, 2014 | 1.250B |
| June 30, 2014 | 945.55M |
| March 31, 2014 | 966.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.62B |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Regeneron Pharmaceuticals, Inc. | 10.02B |
| Sionna Therapeutics, Inc. | 17.47M |
| Biogen, Inc. | 13.24B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.42B |
| Shareholders Equity (Quarterly) | 20.25B |
| Debt to Equity Ratio | 0.0977 |
| Current Ratio | 3.185 |
| Net Debt Paydown Yield | -0.05% |